Clinical Trial Update: Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding study evaluating weekly paclitaxel plus cisplatin in FIGO IB2 and bulky IIA cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Cervical Cancer | Phase 1 | Status: UNKNOWN